Mustang Bio (MBIO)
(Real Time Quote from BATS)
$0.28 USD
-0.03 (-9.85%)
Updated Aug 5, 2024 10:08 AM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for Mustang Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -51.60 | 0.00 | -66.37 | -60.02 | -46.39 |
Depreciation/Amortization & Depletion | 2.34 | 0.00 | 2.31 | 4.11 | 2.08 |
Net Change from Assets/Liabilities | -2.98 | 0.00 | -0.64 | 3.09 | 0.13 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.28 | 0.75 | 11.03 | 15.50 | 10.60 |
Net Cash From Operating Activities | -49.48 | 0.75 | -53.67 | -37.32 | -33.58 |
Property & Equipment | 5.94 | 0.00 | -3.99 | -1.93 | -2.35 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 17.60 |
Other Investing Activities | -0.05 | 0.00 | -1.38 | -2.49 | -1.35 |
Net Cash from Investing Activities | 5.89 | 0.00 | -5.37 | -4.41 | 13.91 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.74 | 0.00 | 70.85 | 93.87 | 51.51 |
Issuance (Repayment) of Debt | -30.38 | 0.00 | 0.00 | -15.75 | 15.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.44 | 0.00 | 0.00 | 0.00 | -1.39 |
Net Cash from Financing Activities | -26.08 | 0.00 | 70.85 | 78.12 | 65.12 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -69.67 | 0.75 | 11.81 | 36.39 | 45.44 |
Cash at Beginning of Period | 76.66 | 0.00 | 98.80 | 62.41 | 16.97 |
Cash at End of Period | 6.98 | 0.00 | 110.62 | 98.80 | 62.41 |
Diluted Net EPS | -6.00 | -11.24 | -11.39 | -17.09 | -19.34 |
Fiscal Year End for Mustang Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -5.19 | -51.60 | -42.99 | -32.93 |
Depreciation/Amortization & Depletion | NA | 0.70 | 2.34 | 1.98 | 1.61 |
Net Change from Assets/Liabilities | NA | -0.90 | -2.98 | -2.88 | -1.74 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.08 | 2.28 | 1.66 | 2.86 |
Net Cash From Operating Activities | NA | -5.32 | -49.48 | -42.22 | -30.20 |
Property & Equipment | NA | 0.00 | 5.94 | 5.97 | -0.03 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | -0.05 | -0.05 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | 5.89 | 5.92 | -0.03 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.05 | 4.74 | 0.34 | 0.09 |
Issuance (Repayment) of Debt | NA | 0.00 | -30.38 | -30.38 | -30.38 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | -0.44 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.05 | -26.08 | -30.04 | -30.29 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -5.27 | -69.67 | -66.34 | -60.52 |
Cash at Beginning of Period | NA | 6.98 | 76.66 | 76.66 | 76.66 |
Cash at End of Period | NA | 1.71 | 6.98 | 10.31 | 16.14 |
Diluted Net EPS | NA | -0.46 | -0.71 | -1.23 | -2.00 |